Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Friday, 12 January 2018

GLOBAL BIOENERGIES: FULL-YEAR REPORT ON THE LIQUIDITY CONTRACT AS OF 29/12/2017

GLOBAL BIOENERGIES    

Published: 17:40 CET 12-01-2018 /GlobeNewswire /Source: GLOBAL BIOENERGIES / : ALGBE /ISIN: FR0011052257


GLOBAL BIOENERGIES: FULL-YEAR REPORT ON THE LIQUIDITY CONTRACT AS OF 29/12/2017

 

Evry (France) - 12 January, 2018 - Global Bioenergies (Euronext Growth : ALGBE) presents the full-year report on the liquidity contract entrusted to the brokerage firm Gilbert Dupont. The following assets appeared on the liquidity account as of
29 December 2017:

 

- Number of shares: 3,871 shares

- Cash balance of the liquidity contract: €53,318.32

 

For the record, as of the half-year report on 30 June 2017, the following assets appeared on the liquidity account:

 

- Number of shares: 4,078 shares

- Cash balance of the liquidity contract: €54,783.68

 

 

 

About GLOBAL BIOENERGIES

Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performance of its process, to operate its demo plant in Germany, and to prepare the first full-scale plant through a joint venture with Cristal Union, named IBN-One. Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 - ALGBE).

 

Stay informed! Subscribe to our newsfeed on
www.global-bioenergies.com

 

Follow us on Twitter: @GlobalBioenergi

 

 

 

Contact

GLOBAL BIOENERGIES

Samuel Dubruque

Chief Financial Officer

Phone:                 +33 1 64 98 20 50

Email: invest@global-bioenergies.com

 



GLOBAL BIOENERGIES PRESS RELEASE



This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of Nasdaq Corporate Solutions clients. Source: GLOBAL BIOENERGIES, 5, rue Henri Desbruères, Evry 91000, France
If you would like to unsubscribe and stop receiving these e-mails click here.